Menicon Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Menicon şirketinin toplam hissedar öz sermayesi ¥84.2B ve toplam borcu ¥65.5B olup, bu da borç-öz sermaye oranını 77.8% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ¥183.3B ve ¥99.1B dir. Menicon 'in FAVÖK'ü ¥8.5B faiz karşılama oranı 17.6 dur. Şirketin ¥44.7B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

77.8%

Borç/özkaynak oranı

JP¥65.53b

Borç

Faiz karşılama oranı	17.6x
Nakit	JP¥44.74b
Eşitlik	JP¥84.24b
Toplam yükümlülükler	JP¥99.06b
Toplam varlıklar	JP¥183.30b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Menicon Co., Ltd. (TSE:7780) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing

Mar 11

Menicon (TSE:7780) Is Paying Out A Dividend Of ¥25.00

Mar 01

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 7780 'nin kısa vadeli varlıkları ( ¥85.1B ) kısa vadeli yükümlülüklerini ( ¥48.5B ) aşıyor.

Uzun Vadeli Yükümlülükler: 7780 şirketinin kısa vadeli varlıkları ( ¥85.1B ) uzun vadeli yükümlülüklerini ( ¥50.6B ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 7780 'nin net borç/öz sermaye oranı ( 24.7% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: 7780 şirketinin borç/öz sermaye oranı son 5 yılda 51% seviyesinden 77.8% seviyesine yükseldi.

Borç Kapsamı: 7780 'nin borcu işletme nakit akışı ( 18.1% ) tarafından iyi bir şekilde karşılanmıyor.

Faiz Kapsamı: 7780 'in borcuna ilişkin faiz ödemeleri EBIT ( 17.6 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.

Menicon Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Menicon Co., Ltd. (TSE:7780) acquired Oculus Visioncare (S) Pte Ltd., Oculus (M) Sdn. Bhd. and PT. Oculus Indonesia from Oculus Private Limited.

Menicon Co., Ltd. (TSE:7780) Not Flying Under The Radar

Menicon Co., Ltd.(TSE:7780) dropped from FTSE All-World Index (USD)

Price target decreased by 14% to JP¥2,196

First quarter 2025 earnings released: EPS: JP¥23.18 (vs JP¥20.75 in 1Q 2024)

Menicon (TSE:7780) Will Want To Turn Around Its Return Trends

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 20%

We Think You Can Look Beyond Menicon's (TSE:7780) Lackluster Earnings

Insufficient new directors

Full year 2024 earnings: EPS misses analyst expectations

Menicon Co., Ltd. (TSE:7780) acquired Laboratoires Dencott.

Menicon Co., Ltd. to Report Q1, 2025 Results on Aug 09, 2024

Menicon (TSE:7780) Has Affirmed Its Dividend Of ¥25.00

Upcoming dividend of JP¥25.00 per share

Menicon Co., Ltd. (TSE:7780) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing

Price target decreased by 8.0% to JP¥2,734

Menicon Co., Ltd. to Report Fiscal Year 2024 Results on May 14, 2024

Menicon (TSE:7780) Is Paying Out A Dividend Of ¥25.00

Menicon Co., Ltd. Announces CFO Changes, Effective from April 1, 2024

Third quarter 2024 earnings released: EPS: JP¥16.48 (vs JP¥34.20 in 3Q 2023)

Consensus EPS estimates fall by 17%

Menicon Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024

Menicon Co., Ltd. Announces the Launch of "1MONTH Menicon MelsME" and "1MONTH MeniconMelsME Toric

Second quarter 2024 earnings released: EPS: JP¥22.93 (vs JP¥28.25 in 2Q 2023)

Price target decreased by 11% to JP¥3,710

First quarter 2024 earnings released: EPS: JP¥20.75 (vs JP¥27.98 in 1Q 2023)

Price target increased by 14% to JP¥4,157

Full year 2023 earnings: EPS misses analyst expectations

Menicon Co., Ltd. Declares A Dividend for the Fiscal Year Ended March 31, 2023, Payable on June 26, 2023

Consensus EPS estimates fall by 11%

Upcoming dividend of JP¥20.00 per share at 0.7% yield

Third quarter 2023 earnings: EPS exceeds analyst expectations

Menicon Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023

Multifocal Colored Contact Lens “2Week Menicon Rei Multifocal” Launch in Japan

Insufficient new directors

Menicon Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023

Price target decreased to JP¥3,874

Menicon Co., Ltd. Announces Price Revision for Menicon 1Day Series

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Menicon Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023

Investor sentiment improved over the past week

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

Menicon Co., Ltd. Announces Dividend for the Year-End Fiscal Year Ended March 31, 2022, Payable on June 24, 2022

Menicon Co., Ltd. Proposes for the Fiscal Year Ended March 31, 2022, Payable on June 24, 2022

Now 21% undervalued after recent price drop

Price target decreased to JP¥4,150

Insufficient new directors

Menicon Co., Ltd. Announces the Launch of Miru 1day UpSide toric in Europe

Menicon Co., Ltd., Annual General Meeting, Jun 23, 2022

Menicon Co., Ltd., Annual General Meeting, Jun 23, 2022

Upcoming dividend of JP¥17.50 per share

Menicon Co., Ltd. Announces the Launch of Menicon BloomTM

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Menicon Co., Ltd. Provides Earning Guidance for the Fiscal Year Ending March 31, 2022

Insufficient new directors

Menicon Co., Ltd. Announces Daily Disposable Lens “1Day Menicon PremiO Multifocal” Launch in Japan

Second quarter 2022 earnings released: EPS JP¥22.63 (vs JP¥23.97 in 2Q 2021)

Price target increased to JP¥4,886

First quarter 2022 earnings released: EPS JP¥44.72 (vs JP¥36.76 in 1Q 2021)

Price target increased to JP¥8,343

Menicon Co., Ltd. Launches Daily Disposable Circle Lens 1Day Menicon Rei in Japan

Full year 2021 earnings released: EPS JP¥158 (vs JP¥112 in FY 2020)

Menicon Co., Ltd. Announces Year-End Dividend for the Fiscal Year Ended March 31, 2021, Payable on June 25, 2021

Menicon Co., Ltd. Announces Dividend for the Fiscal Year Ended March 31, 2021

Upcoming dividend of JP¥30.00 per share

Menicon Co., Ltd. to Report Fiscal Year 2021 Results on May 13, 2021

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin